New drug aims to limit heart damage after severe attack
NCT ID NCT07306182
Summary
This study is testing an experimental drug called SGC001 in people who are having a major heart attack in the front of the heart. The goal is to see if the drug can reduce the amount of permanent heart muscle damage and lower the risk of future heart problems like heart failure or death. Participants will be randomly assigned to receive either the real drug or a placebo (dummy treatment) along with their standard emergency heart procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.